The effect of colchicine on pyrin and pyrin interacting proteins

Ekim Z Taskiran1, Arda Cetinkaya, Banu Balci-Peynircioglu

  • 1Department of Medical Biology, Hacettepe University, Ankara, Turkey.

Insights

Colchicine, a treatment for familial Mediterranean fever (FMF), impacts pyrin and its related proteins. This study reveals colchicine affects actin cytoskeleton organization and MEFV gene expression, potentially explaining its efficacy in FMF.

Area of Science:

  • Molecular Biology
  • Immunology
  • Cell Biology

Background:

  • Familial Mediterranean fever (FMF) is the most common autoinflammatory disease, caused by mutations in the MEFV gene encoding pyrin.
  • Pyrin's role in inflammation regulation is not fully understood, and the precise mechanism of colchicine's efficacy in FMF is unclear.
  • Colchicine, a microtubule inhibitor, is a highly effective prophylactic treatment for FMF.

Purpose of the Study:

  • To investigate the specific cellular mechanisms underlying colchicine's efficacy in FMF.
  • To explore the potential direct effects of colchicine on pyrin and its interacting proteins.
  • To elucidate the connection between colchicine, pyrin, and the MEFV gene.

Main Methods:

  • Investigated the effect of colchicine on PSTPIP1 filaments and ASC speck formation in transfected cells.
  • Analyzed MEFV gene expression in THP-1 cells treated with colchicine.
  • Examined the impact of colchicine on the actin cytoskeleton organization in THP-1 cells.

Main Results:

  • Colchicine treatment inhibited the formation of reticulated fibrils by PSTPIP1 filaments and reduced ASC speck rates.
  • Colchicine was found to down-regulate MEFV gene expression in THP-1 cells.
  • Colchicine induced significant re-organization of the actin cytoskeleton in THP-1 cells, where pyrin is an actin-binding protein.

Conclusions:

  • Colchicine's efficacy in FMF may be linked to its effects on pyrin-interacting proteins and the actin cytoskeleton.
  • Down-regulation of MEFV expression by colchicine, potentially mediated by actin cytoskeleton changes, could explain its therapeutic benefit.
  • This study highlights a novel connection between colchicine and pyrin, offering insights into FMF pathogenesis and treatment.

Related Concept Videos

Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
Allosteric Proteins-ATCase01:19

Allosteric Proteins-ATCase

Binding sites linkages can regulate a protein's function.  For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to  N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
Factors Affecting Protein-Drug Binding: Drug Interactions01:23

Factors Affecting Protein-Drug Binding: Drug Interactions

Drug interactions are a critical aspect of pharmacology and can occur when two or more drugs compete for the same binding site. This competition can result in one drug displacing another, altering the effect of the displaced drug. Drug interactions are complex processes that rely heavily on how much of the displacer drug is present and how strongly it can bind to the same sites as the displaced drug.
Displacement interactions can have varying outcomes, ranging from toxicity to virtually...
Inhibitors of Bacterial DNA Synthesis01:28

Inhibitors of Bacterial DNA Synthesis

Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...